Alvotech completes $59.7 million private placement

Alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of approximately us$59.7 million, at current exchange rates, of subordinated convertible bonds (the “bonds”), convertible into new fully paid ordinary shares of alvotech.
ALVO Ratings Summary
ALVO Quant Ranking